Andreas Lind Selected Research

Cyclic AMP (AMP, Cyclic)

7/2011

An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Lind Research Topics

Disease

9	COVID-19 12/2023 - 10/2020
6	Respiratory Insufficiency (Respiratory Failure) 12/2022 - 01/2020
5	Infections 12/2022 - 07/2011
3	Disease Progression 01/2016 - 07/2011
3	HIV Infections (HIV Infection) 08/2015 - 07/2011
2	Inflammation (Inflammations) 12/2022 - 10/2022
2	Hypersensitivity (Allergy) 09/2013 - 08/2012
1	Breakthrough Infections 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Thrombotic Microangiopathies 02/2021
1	Pneumonia (Pneumonitis) 01/2020
1	Hypercapnia 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2015
1	Persistent Infection 01/2014

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 01/2023 - 07/2011
3	AntigensIBA 10/2022 - 01/2014
3	Oxygen (Dioxygen)IBA 01/2021 - 01/2020
2	ChemokinesIBA 12/2022 - 09/2013
2	AntibodiesIBA 10/2022 - 01/2022
2	Complement System Proteins (Complement)IBA 02/2021 - 10/2020
2	CytokinesIBA 12/2020 - 09/2013
2	Vacc-4xIBA 09/2013 - 08/2012
1	S100A12 ProteinIBA 12/2023
1	COVID-19 VaccinesIBA 12/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2022
1	Syndecan-1 (Syndecan 1)IBA 10/2022
1	NeopterinIBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	InterferonsIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Complement Factor B (Factor B)IBA 02/2021
1	eculizumab FDA Link 02/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	Lipopolysaccharide ReceptorsIBA 01/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Chemotactic FactorsIBA 12/2020
1	Complement Inactivating AgentsIBA 10/2020
1	Penicillin G (Benzylpenicillin)FDA LinkGeneric 01/2020
1	AIDS VaccinesIBA 09/2013
1	Granzymes (Granzyme)IBA 09/2013
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 09/2013
1	HMGB1 Protein (HMG1)IBA 06/2013
1	LipopolysaccharidesIBA 07/2011
1	Celecoxib (Celebrex)FDA Link 07/2011
1	Cyclic AMP (AMP, Cyclic)IBA 07/2011
1	ProstaglandinsIBA 07/2011
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2011

Therapy/Procedure

2	Therapeutics 10/2020 - 08/2015
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Critical Care (Surgical Intensive Care) 12/2022
1	Length of Stay 10/2020
1	Art Therapy 08/2015